New diabetes drug tested in people with kidney problems
NCT ID NCT06370819
First seen Apr 11, 2026 · Last updated Jun 17, 2026 · Updated 13 times
Summary
This study looked at how a new medicine for type 2 diabetes, called NNC0519-0130, is processed in the body when people have different levels of kidney function. 36 adults with normal, mildly, moderately, or severely reduced kidney function received a single dose. Researchers measured the drug levels in their blood to see if kidney problems change how the medicine works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Campus Charité Mitte - Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.